Sales Growth YoY (Last Twelve Months): Matinas BioPharma (MTNB)

Graphic logo of Matinas BioPharma Holdings (MTNB)

Matinas BioPharma develops innovative drug delivery systems via its LNC platform, attracting patients with severe infections to MAT2203 trials due to low toxicity. The annual sales growth rate over a 12-month period demonstrates revenue dynamics, where the value of 0.00 characterizes this level. The development strategy relies on the expansion of LNC technologies and the broadening of B2B licensing to capture the global pharmaceutical market.

Sales Growth YoY (Last Twelve Months): matinasbiopharma.com (MTNB) for 02/11/2024 - 11/18/2026

Summary analytical data breakdowns for Matinas BioPharma (MTNB)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:MTNB (Matinas BioPharma Holdings, Inc.)
Mass-produced product of Matinas BioPharma Holdings Inc.

Revenue dynamics for Matinas BioPharma (MTNB), which is based on proprietary drug delivery technology, are assessed by comparing total revenues over the last 12 months with the same period last year to identify expansion rates. An analysis of the trailing twelve months (TTM) growth in operating sales revenue determines whether inertial demand for the treatment of metabolic diseases is converting into sustainable financial growth without excessive costs.

Competitor analysis for Matinas BioPharma

Ascendis (ASND) - Trailing Twelve Months Revenue Growth|MDGL - Sales Growth YoY (Last Twelve Months)|CORT: Sales Growth YoY (Last Twelve Months)|RYTM: Sales Growth YoY (TTM)|AKRO - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) Metsera Therapeutics|MoonLake Corp (MLTX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (Last Twelve Months) crinetics.com (CRNX)|Revenue Growth YoY (Last 12 Months) newamsterdampharma.com NAMS|Sales Growth YoY (Last Twelve Months) Soleno Therapeutics Inc SLNO|Sales Growth YoY (TTM) Amicus Therapeutics Inc FOLD|89bio Corp - Sales Growth YoY (TTM)|Revenue Growth Rate YoY (Last Twelve Months) Agios Pharmaceuticals Inc (AGIO)|Structure Therapeutics (GPCR) - Sales Growth YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) MiMedx Group, Inc.|Sales Growth YoY (Last Twelve Months) Rezolute Bio|Lexicon Pharmaceuticals, Inc. (LXRX) - Annual Revenue Growth (Last Twelve Months)|Sales Growth YoY (TTM) MBX|Revenue Growth YoY (Last 12 Months) Altimmune, Inc. ALT|Sales Growth YoY (TTM) AARD (Aardvark Pharma)|Sagimet Biosciences Inc. (SGMT) - Trailing Twelve Months Revenue Growth|BIOA: Revenue Growth YoY (Last 12 Months)|Revenue Dynamics YoY (Last Twelve Months) BMEA (Biomea Fusion)|QNCX (quincetx.com) - Revenue Growth YoY (Last 12 Months)|Fractyl - Revenue Dynamics YoY (Last Twelve Months)|VTVT (vTv Therapeutics Inc) - Sales Growth YoY (TTM)|Agape ATP - Trailing Twelve Months Sales Growth|Revenue Growth YoY (Last 12 Months) PLUR (Pluri Inc)|Annual Revenue Growth (Last Twelve Months) Synlogic Inc.|Sales Growth YoY (Last Twelve Months) Lipocine Inc. LPCN|Annual Revenue Growth (Last Twelve Months) Spruce Biosciences (SPRB)|GLTO: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth CTCX|LUMO (Lumos Pharma) - Revenue Growth YoY (Last 12 Months)|Sales Growth YoY (Last 12 Months) ONVO|RDUS (Radius Pharmaceuticals) - Sales Growth YoY (TTM)